Compounds > erythrosine

erythrosine and ritonavir

erythrosine has been researched along with ritonavir in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drewe, J; Fricker, G; Gutmann, H; Miller, DS; Toeroek, M1
Arimori, K; Fujii, J; Hamada, A; Nakano, M; Shiraki, N; Yasuda, K1
Annaert, P; Augustijns, P; Camus, S; Snoeys, J; Van Pelt, J; Ye, ZW1
Annaert, P; Augustijns, P; Camus, S; Ye, ZW1
Abbès, S; Bissinger, R; Bouguerra, G; Lang, F; Waibel, S1
Arimany-Nardi, C; Cedeño, S; Clotet, B; Erkizia, I; Martinez-Picado, J; Minuesa, G; Moltó, J; Pastor-Anglada, M1

Other Studies

6 other study(ies) available for erythrosine and ritonavir

ArticleYear
Interactions of HIV protease inhibitors with ATP-dependent drug export proteins.
    Molecular pharmacology, 1999, Volume: 56, Issue:2

    Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cyclosporine; Fluoresceins; HIV Protease Inhibitors; Killifishes; Methotrexate; Mitochondrial Proteins; Ribosomal Proteins; Ritonavir; Saccharomyces cerevisiae Proteins; Saquinavir

1999
Inhibitory effect of human immunodeficiency virus protease inhibitors on multidrug resistance transporter P-glycoproteins.
    Biological & pharmaceutical bulletin, 2000, Volume: 23, Issue:12

    Topics: Animals; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Drug Interactions; Fluoresceins; Fluorescent Dyes; HIV Protease Inhibitors; HIV Reverse Transcriptase; Humans; Kinetics; LLC-PK1 Cells; Nelfinavir; Reverse Transcriptase Inhibitors; Ritonavir; Swine; Transfection

2000
Species-specific interaction of HIV protease inhibitors with accumulation of cholyl-glycylamido-fluorescein (CGamF) in sandwich-cultured hepatocytes.
    Journal of pharmaceutical sciences, 2010, Volume: 99, Issue:6

    Topics: Animals; Bile Acids and Salts; Biological Transport; Darunavir; Dogs; Dosage Forms; Female; Fluoresceins; Hepatocytes; HIV Protease Inhibitors; Humans; Indinavir; Liver; Male; Middle Aged; Rats; Rats, Wistar; Ritonavir; Species Specificity; Sulfonamides; Sus scrofa

2010
Interaction of eight HIV protease inhibitors with the canalicular efflux transporter ABCC2 (MRP2) in sandwich-cultured rat and human hepatocytes.
    Biopharmaceutics & drug disposition, 2010, Volume: 31, Issue:2-3

    Topics: Animals; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carbamates; Cells, Cultured; Fluoresceins; Furans; Hepatocytes; HIV Protease Inhibitors; Humans; Indinavir; Liver; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Nelfinavir; Rats; Rats, Wistar; Ritonavir; Saquinavir; Sulfonamides

2010
Ritonavir-Induced Suicidal Death of Human Erythrocytes.
    Basic & clinical pharmacology & toxicology, 2016, Volume: 119, Issue:1

    Topics: Annexin A5; Apoptosis; Calcium; Cell Size; Ceramides; Erythrocyte Membrane; Erythrocytes; Fluoresceins; Humans; Oxidative Stress; Phosphatidylserines; Reactive Oxygen Species; Ritonavir

2016
P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphigh cells and correlates with HIV-1 viral load.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:10

    Topics: Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B; Benzylidene Compounds; CD4-Positive T-Lymphocytes; Cell Line; Cells, Cultured; Fluoresceins; Healthy Volunteers; HIV Infections; HIV-1; Humans; Immunologic Memory; Raltegravir Potassium; Ritonavir; Tetrahydroisoquinolines; Viral Load; Viremia; Virus Replication

2016